Nephron sparing surgery in patients with extension of renal cell carcinoma to the main renal vein: Intrarenal and extrarenal thrombectomy
Shchukin, D., Lesovoy, V., Polyakov, M., Khareba, G., Antonyan, I., Maltsev, A., Harahatyi, A.
Published in European urology open science (Online) (01.07.2020)
Published in European urology open science (Online) (01.07.2020)
Get full text
Journal Article
NEPHRON-SPARING SURGERY IN PATIENTS WITH RENAL CELL CARCINOMA EXTENDING TO THE MAIN RENAL VEIN: INTRARENAL AND EXTRARENAL THROMBECTOMY
Shchukin, D, Lisova, G, Khareba, G, Polyakov, M, Antonyan, I, Kopytsya, M, Harahatyi, A, Shus, A
Published in Georgian medical news (01.12.2019)
Get more information
Published in Georgian medical news (01.12.2019)
Journal Article
A subgroup analysis from the IMvigor130 study in patients with upper tract vs. lower tract locally advanced or metastatic urothelial carcinoma treated with atezolizumab plus platinum-based chemotherapy
Bamias, A., De Santis, M., Grande, E., Marina, M., Li, J-R., Puente, J., Izumi, K., Lee, J.L., Kose, F., Antonyan, I., Ding, B., Patel, H., Davis, I.
Published in European urology open science (Online) (01.11.2020)
Published in European urology open science (Online) (01.11.2020)
Get full text
Journal Article
The results of open ureterocalicostomy for reconstruction of the upper urinary tract
Demchenko, V., Shchukin, D., Khareba, G., Mozzhakov, P., Antonyan, I., Lisova, G., Harahatyi, A.
Published in European urology (01.06.2021)
Published in European urology (01.06.2021)
Get full text
Journal Article
Clinical benefit and safety profile of darolutamide in patients who crossed over to darolutamide from placebo during the open-label period of the phase 3 ARAMIS study
Feyerabend, S., Shore, N., Smith, M., Kopyltsov, E., Antonyan, I., Damber, J., Gasparro, D., Yildirim, A., Hellstrom, M., Vjaters, E., Ortiz, J., Srinivasan, S., Sarapohja, T., Fizazi, K.
Published in European urology (01.06.2021)
Published in European urology (01.06.2021)
Get full text
Journal Article
LBA66 IMmotion010: Efficacy and safety from the phase III study of atezolizumab (atezo) vs placebo (pbo) as adjuvant therapy in patients with renal cell carcinoma (RCC) at increased risk of recurrence after resection
Bex, A., Uzzo, R., Karam, J.A., Master, V.A., Donskov, F., Suárez, C., Albiges, L., Rini, B.I., Tomita, Y., Kann, A., Procopio, G., Massari, F., Zibelman, M., Antonyan, I., Huseni, M., Basu, D., Ci, B., Leung, W., Khan, O., Pal, S.K.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
RESULTS OF EXTRACORPOREAL NEPHRON-SPARING SURGERY FOR RENAL CELL CARCINOMA WITH AUTOTRANSPLANTATION
Lesovoy, V, Shchukin, D, Khareba, G, Antonyan, I, Lisova, G, Demchenko, V, Olkhovska, V
Published in Georgian medical news (01.10.2020)
Get more information
Published in Georgian medical news (01.10.2020)
Journal Article